| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.37 | 2e-26 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.33 | 9e-22 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.31 | 1e-17 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-14 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-12 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-10 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-08 |